Table 2.
Topographical distribution of 465 lymph nodes evaluated in 78 patients with gallbladder cancer n (%)
| Node group | Patients with node group | Lymph nodes evaluated | Patients with positive | Positive nodes |
| evaluated | nodes | |||
| Cystic duct1 | 41 (53.95) | 46 (9.89) | 18 (23.08) | 19 (19.39) |
| Pericholedochal1 | 68 (81.18) | 146 (31.40) | 20 (25.64) | 29 (29.59) |
| Periportal1 | 47 (60.26) | 74 (15.91) | 12 (15.38) | 18 (18.37) |
| Hepatic artery1 | 48 (61.54) | 69 (14.84) | 10 (12.82) | 12 (12.24) |
| Posterosuperior pancreaticoduodenal2 | 22 (28.21) | 56 (12.04) | 6 (7.69) | 12 (12.24) |
| Hilar1 | 18 (23.08) | 26 (5.59) | 4 (5.13) | 6 (6.12) |
| Right celiac2 | 8 (10.26) | 21 (4.52) | 1 (1.28) | 2 (2.04) |
| Perigastric2 | 4 (5.13) | 6 (1.29) | 0 (0.00) | 0 (0.00) |
| Superior mesenteric artery2 | 6 (7.69) | 11 (2.37) | 0 (0.00) | 0 (0.00) |
| Paraaortic2 | 6 (7.69) | 10 (2.15) | 0 (0.00) | 0 (0.00) |
| Sum | 78 (100) | 465 (100) | 37 (47.44) | 98 (100) |
1
First-station nodes;
2
Second-station nodes; according to the American Joint Committee on Cancer cancer staging manual (7th edition). Here, hilar lymph nodes classified as first-station nodes and perigastric lymph nodes classified as second-station nodes.